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Omega-3 Fatty Acids Prevent Muscle
Degeneration in Muscular Dystrophy
Muscular dystrophies are degenerative neuromuscular
disorders with limited treatment options. To determine
whether a diet rich in -3 fatty acids could affect muscu-
lar degeneration, Fiaccavento et al (Am J Pathol 2010,
177:2176–2184) examined a hamster model of neurode-
generation. A diet enriched in flaxseed-derived -3 -lin-
olenic fatty acid prevented muscle degeneration in this
model. Furthermore, the -3-enriched diet led to both
morphological and function improvement of myocytes as
well as myocyte proliferation to repair damaged muscle.
These findings suggest that diet may be a viable treat-
ment strategy to ameliorate muscular dystrophy.
Toll-Like Receptors (TLRs) Limit Herpes
Simplex Virus 1 (HSV-1) Infection
HSV-1 infection is widespread and often asymptomatic;
however, infection may result in fatal encephalitis. Al-
though innate immunity plays a key role in controlling
HSV-1 infection, the specific role of individual TLRs re-
mains unknown. Using a murine model of intranasal
HSV-1 infection, Lima et al (Am J Pathol 2010, 177:2433–
2445) found that mice deficient in either TLR 9 or double
deficient in TLR 2 and TLR 9 were more susceptible to
infection than control animals. Cytokine and chemokine
expression levels were altered in both the trigeminal gan-
glia and brains of these animals compared with control
animals. Thus, HSV-1 infection is likely controlled in a
TLR-dependent mechanism in the trigeminal ganglia of
infected individuals.
Insulin-Like Growth Factor 2 Receptor
(IGF2R) in HIV Encephalitis (HIVE)
IGF2R, which functions by removing growth factors from
both tissues and blood via direct lysosomal targeting, is
highly expressed in microglial nodules of individuals af-
fected by HIVE. However, due to perinatal lethality of
models deficient in IGF2R, the function of IGF2R in the
CNS remains unknown. Suh et al (Am J Pathol 2010,
177:2446–2458) hypothesized that IGF2R positively reg-
ulated HIV infection in the CNS. In vitro, IGF2R expression
was up-regulated as a result of interferon- signaling,
and IGF2R was shown to increase levels of HIV infection
in brain-derived cells, including microglia. Moreover,
RNAi-mediated depletion of IGF2R increased levels of
the inflammatory chemokine IP-10 in infected cells.
IGF2R may therefore provide a novel therapeutic target
for HIV/AIDS.
Microglia in Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disorder
characterized by neuroinflammation and the deposition
of -amyloid (A) plaques. Microglia, resident inflamma-
tory cells in the brain, are activated in Alzheimer’s dis-
ease patients; however, the role microglia play in Alzhei-
mer’s disease pathology may vary depending on local
conditions. Lee et al (Am J Pathol 2010, 177:2549–2562)
discovered that models of Alzheimer’s disease that
lacked CXC3R1, the receptor for the chemokine CXC3L1,
had reduced levels of A deposition and a decrease in
the number of resident microglia. Microglia in these mice
expressed altered levels of chemokines and cytokines,
and CXC3L1-CXC3R1 signaling reduced microglial
phagocytic capacity. Therefore, CXC3R1 deficiency
leads to enhanced phagocytic clearance of A by
microglia.
Mutations in Mesenchymal Stem/Progenitor
Cells May Lead to Soft Tissue Sarcomas
Soft tissue sarcomas affect nonepithelial and extraskel-
etal tissues such as muscles, blood vessels, and nerves;
however, the pathogenesis of this disease remains poorly
understood. To explore what role two tumor suppressor
genes frequently mutated in human soft tissue sarcomas,
p53 and Rb, play in disease initiation, Choi et al (Am J
Pathol 2010, 177:2645–2658) developed a model with
inducible deficiency in these genes. Upon deletion, these
mice developed soft tissue sarcomas, and disease de-
velopment was dependent on local mesenchymal stem/
progenitor cells and not bone marrow–derived cells.
Therefore, dermal mesenchymal stem/progenitor cells
may be the primary cell type affected by p53 and Rb
mutation, resulting in soft tissue sarcomas.
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